Stock Price
29.74
Daily Change
1.14 3.97%
Monthly
-14.92%
Yearly
-22.03%
Q2 Forecast
27.85

Qiagen NV reported $402.61M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
argenx SE USD 1.66B 458.83M Dec/2025
Avita Medical AUD 9.11M 2.26M Dec/2025
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Ionis Pharmaceuticals USD 74M 8M Mar/2026
IQVIA Holdings USD 3.38B 52M Mar/2026
Moderna USD 71M 113M Mar/2026
Organon & Co USD 1.33B 153M Dec/2025
Qiagen NV USD 402.61M 9.05M Dec/2025
Revvity USD 691.38M 53.29M Mar/2026
Tectonic Therapeutic USD 0 270K Dec/2023
Viatris USD 3.08B 45M Mar/2026
Xeris Pharmaceuticals USD 51.05M 2.7M Dec/2025